US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 3.510
  • -0.040-1.13%
Close Oct 18 16:00 ET
  • 3.500
  • -0.010-0.28%
Post 18:53 ET
219.03MMarket Cap-10323P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
-23.67%-97.05M
9.89%-19.7M
-23.52%-27.88M
Net income from continuing operations
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
Depreciation and amortization
-33.69%376K
-15.37%479K
-10.02%2.17M
-14.04%508K
-13.09%531K
-16.12%567K
5.60%566K
-4.02%2.41M
-4.83%591K
-1.29%611K
Change In working capital
-112.31%-96K
40.93%-1.65M
-49.10%-4.61M
-132.43%-1.03M
80.88%-1.57M
-72.74%780K
-205.25%-2.79M
73.98%-3.09M
200.16%3.18M
-57.29%-8.22M
-Change in receivables
-318.85%-2.33M
313.08%537K
-109.04%-308K
-92.51%43K
-74.41%76K
-86.91%-557K
-95.41%130K
408.14%3.41M
123.25%574K
158.12%297K
-Change in prepaid assets
-39.40%463K
253.83%803K
-530.59%-1.07M
-181.20%-622K
27.99%-692K
1,176.06%764K
-643.75%-522K
-26.87%-170K
75.69%766K
58.98%-961K
-Change in payables and accrued expense
107.17%1.94M
-33.63%-2.82M
-170.21%-1.68M
-96.27%92K
91.53%-593K
-83.92%934K
-11.81%-2.11M
-121.25%-621K
546.98%2.47M
-559.95%-7.01M
-Change in other current assets
-102.78%-1K
-68.92%23K
106.02%94K
-250.00%-21K
-28.57%5K
102.79%36K
127.01%74K
-4,438.89%-1.56M
73.91%-6K
-41.67%7K
-Change in other working capital
59.70%-160K
47.37%-190K
60.26%-1.65M
15.65%-523K
34.05%-368K
69.18%-397K
78.55%-361K
69.51%-4.15M
58.64%-620K
85.72%-558K
Cash from discontinued investing activities
Operating cash flow
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
-23.67%-97.05M
9.89%-19.7M
-23.52%-27.88M
Investing cash flow
Cash flow from continuing investing activities
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
109.57%12.41M
-299.85%-36.36M
97.86%-2.28M
Net PPE purchase and sale
--0
83.63%-28K
74.12%-508K
33.62%-77K
77.03%-65K
85.20%-195K
30.49%-171K
-14.59%-1.96M
77.65%-116K
22.89%-283K
Net investment purchase and sale
-162.32%-12.51M
140.69%38.16M
-351.70%-36.18M
150.85%18.43M
1,056.16%19.09M
-38.65%20.07M
-571.09%-93.77M
111.24%14.38M
-322.69%-36.25M
98.12%-2M
Cash from discontinued investing activities
Investing cash flow
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
109.57%12.41M
-299.85%-36.36M
97.86%-2.28M
Financing cash flow
Cash flow from continuing financing activities
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
0
-94.95%142K
33,719.83%117.69M
-54.79%84.32M
-75.53%218K
-41.30%80.95M
Net common stock issuance
--0
--0
45.22%117.35M
--0
--0
--0
--117.35M
-55.81%80.8M
36.36%-49K
-40.34%80.85M
Proceeds from stock option exercised by employees
165.49%377K
374.43%1.65M
-77.92%777K
7.49%287K
--0
-94.95%142K
0.00%348K
-4.06%3.52M
-72.45%267K
-96.08%93K
Cash from discontinued financing activities
Financing cash flow
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
--0
-94.95%142K
33,719.83%117.69M
-54.79%84.32M
-75.53%218K
-41.30%80.95M
Net cash flow
Beginning cash position
14.86%41.15M
-26.35%26.66M
-0.86%36.19M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
-0.86%36.19M
-37.22%36.5M
38.26%92.03M
-28.73%41.25M
Current changes in cash
6,189.58%46.77M
4,082.14%14.5M
-2,936.62%-9.54M
91.91%-4.52M
-107.65%-3.89M
-111.23%-768K
82.66%-364K
98.55%-314K
-85.76%-55.84M
484.14%50.79M
End cash Position
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-26.35%26.66M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
-0.86%36.19M
-0.86%36.19M
38.26%92.03M
Free cash flow
380.74%58.9M
-4.22%-25.31M
7.62%-91.47M
-17.28%-23.24M
18.44%-22.97M
26.86%-20.98M
-8.66%-24.29M
-23.47%-99.01M
11.46%-19.81M
-22.78%-28.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M-9.09%-24.12M-23.67%-97.05M9.89%-19.7M-23.52%-27.88M
Net income from continuing operations 332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M
Depreciation and amortization -33.69%376K-15.37%479K-10.02%2.17M-14.04%508K-13.09%531K-16.12%567K5.60%566K-4.02%2.41M-4.83%591K-1.29%611K
Change In working capital -112.31%-96K40.93%-1.65M-49.10%-4.61M-132.43%-1.03M80.88%-1.57M-72.74%780K-205.25%-2.79M73.98%-3.09M200.16%3.18M-57.29%-8.22M
-Change in receivables -318.85%-2.33M313.08%537K-109.04%-308K-92.51%43K-74.41%76K-86.91%-557K-95.41%130K408.14%3.41M123.25%574K158.12%297K
-Change in prepaid assets -39.40%463K253.83%803K-530.59%-1.07M-181.20%-622K27.99%-692K1,176.06%764K-643.75%-522K-26.87%-170K75.69%766K58.98%-961K
-Change in payables and accrued expense 107.17%1.94M-33.63%-2.82M-170.21%-1.68M-96.27%92K91.53%-593K-83.92%934K-11.81%-2.11M-121.25%-621K546.98%2.47M-559.95%-7.01M
-Change in other current assets -102.78%-1K-68.92%23K106.02%94K-250.00%-21K-28.57%5K102.79%36K127.01%74K-4,438.89%-1.56M73.91%-6K-41.67%7K
-Change in other working capital 59.70%-160K47.37%-190K60.26%-1.65M15.65%-523K34.05%-368K69.18%-397K78.55%-361K69.51%-4.15M58.64%-620K85.72%-558K
Cash from discontinued investing activities
Operating cash flow 383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M-9.09%-24.12M-23.67%-97.05M9.89%-19.7M-23.52%-27.88M
Investing cash flow
Cash flow from continuing investing activities -162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M-577.85%-93.94M109.57%12.41M-299.85%-36.36M97.86%-2.28M
Net PPE purchase and sale --083.63%-28K74.12%-508K33.62%-77K77.03%-65K85.20%-195K30.49%-171K-14.59%-1.96M77.65%-116K22.89%-283K
Net investment purchase and sale -162.32%-12.51M140.69%38.16M-351.70%-36.18M150.85%18.43M1,056.16%19.09M-38.65%20.07M-571.09%-93.77M111.24%14.38M-322.69%-36.25M98.12%-2M
Cash from discontinued investing activities
Investing cash flow -162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M-577.85%-93.94M109.57%12.41M-299.85%-36.36M97.86%-2.28M
Financing cash flow
Cash flow from continuing financing activities 165.49%377K-98.60%1.65M40.08%118.12M31.65%287K0-94.95%142K33,719.83%117.69M-54.79%84.32M-75.53%218K-41.30%80.95M
Net common stock issuance --0--045.22%117.35M--0--0--0--117.35M-55.81%80.8M36.36%-49K-40.34%80.85M
Proceeds from stock option exercised by employees 165.49%377K374.43%1.65M-77.92%777K7.49%287K--0-94.95%142K0.00%348K-4.06%3.52M-72.45%267K-96.08%93K
Cash from discontinued financing activities
Financing cash flow 165.49%377K-98.60%1.65M40.08%118.12M31.65%287K--0-94.95%142K33,719.83%117.69M-54.79%84.32M-75.53%218K-41.30%80.95M
Net cash flow
Beginning cash position 14.86%41.15M-26.35%26.66M-0.86%36.19M-66.13%31.17M-15.00%35.06M4.13%35.83M-0.86%36.19M-37.22%36.5M38.26%92.03M-28.73%41.25M
Current changes in cash 6,189.58%46.77M4,082.14%14.5M-2,936.62%-9.54M91.91%-4.52M-107.65%-3.89M-111.23%-768K82.66%-364K98.55%-314K-85.76%-55.84M484.14%50.79M
End cash Position 150.78%87.92M14.86%41.15M-26.35%26.66M-26.35%26.66M-66.13%31.17M-15.00%35.06M4.13%35.83M-0.86%36.19M-0.86%36.19M38.26%92.03M
Free cash flow 380.74%58.9M-4.22%-25.31M7.62%-91.47M-17.28%-23.24M18.44%-22.97M26.86%-20.98M-8.66%-24.29M-23.47%-99.01M11.46%-19.81M-22.78%-28.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data